Format

Send to

Choose Destination
See comment in PubMed Commons below
J Arthroplasty. 2014 Jun;29(6):1225-30. doi: 10.1016/j.arth.2013.12.031. Epub 2014 Jan 8.

The effect of chronic kidney disease on total hip arthroplasty.

Author information

1
Southern California Permanente Medical Group, Department of Orthopaedic Surgery, Los Angeles, California.
2
Kaiser Permanente, Surgical Outcomes and Analysis Unit, Clinical Analysis, San Diego, California.
3
Southern California Permanente Medical Group, Department of Orthopaedic Surgery, Orange County, Irvine, California.

Abstract

Patients with chronic kidney disease (CKD) undergoing total hip arthroplasty (THA) were evaluated for risk of revision, surgical site infection (SSI), thromboembolic events, mortality and readmission. 20,720 primary TKA cases were included (smaller sample for readmission evaluation, N = 9322). The prevalence of CKD among THA patients was 6.1% (N = 1269). After adjustment for age, gender, race, general health, and diabetes, CKD patients were at 1.4 (95% confidence interval 1.1-1.8) increased risk of readmission within 90 days. The adjusted risks for revision (overall, aseptic, and septic), SSI (deep and superficial), deep vein thrombosis, pulmonary embolism, and mortality (30-day, 90-day, ever) were not significantly different between patients with CKD and those without CKD. However, increased risk for 90-day readmission underscores that CKD patients are a fundamentally different population of patients.

KEYWORDS:

hip arthroplasty; implant longevity; kidney disease; mortality; perioperative morbidity; total joint registry

PMID:
24556110
DOI:
10.1016/j.arth.2013.12.031
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center